Discussion
The U.S. Food and Drug Administration (FDA) has set a date for next year by which it will decide whether or not to approve a…
Myeloma
Myeloma is a rare blood cancer that begins in plasma cells, a type of white blood cell normally responsible for producing antibodies that help fight off infectious pathogens and other threats.
While myeloma treatment can drive the disease into remission, sometimes for long periods of time, the cancer will often come back after a few months or years, and additional treatments will be needed.
Latest news
Discussion
Discussion
Some days, I watch my mother try to stand, and my breath catches. The doctors have warned us about bone weakness — how…
Discussion
For seven years, I have kept up on developments in multiple myeloma research. I follow the latest treatments, the newest studies, and…
Discussion
The U.S. Food and Drug Administration (FDA) has approved a new version of Sarclisa (isatuximab), an approved treatment for multiple myeloma sold by…
Discussion
Regulatory authorities in two countries have given the green light for clinical testing of a novel treatment from Mabwell Bioscience — which the company…
Discussion
I find myself watching my mother’s hands more often these days. It shouldn’t come as a surprise, though. After all, observation is one of…
